US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist
  • 0.428
  • -0.012-2.75%
Close Nov 22 16:00 ET
  • 0.429
  • +0.001+0.30%
Post 20:01 ET
17.77MMarket Cap-445P/E (TTM)

About Cognition Therapeutics Company

Cognition Therapeutics, Inc. is a clinical stage neuroscience company which engages in developing drugs that help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders. It offers the CT1812 which aims to restore the damaged cellular processes that drive diseases such as Alzheimer’s disease, dry age-related macular degeneration, geographic atrophy and other conditions. The company was founded by Franz F. Hefti, Gilbert M. Rishton, and Susan M. Catalano on August 21, 2007 and is headquartered in Purchase, NY.

Company Profile

SymbolCGTX
Company NameCognition Therapeutics
Listing DateOct 8, 2021
Issue Price12.00
Founded2007
CEOMs. Lisa Ricciardi
MarketNASDAQ
Employees28
Fiscal Year Ends12-31
Address2500 Westchester Avenue
CityPurchase
ProvinceNew York
CountryUnited States of America
Zip Code10577
Phone1-412-481-2210
Websitehttp://www.cogrx.com

Company Executives

  • Name
  • Position
  • Salary
  • Lisa Ricciardi
  • Director, Chief Executive Officer and President
  • 1.66M
  • Dr. Anthony Caggiano, M.D.,PhD
  • Chief Medical Officer and Head of R&D
  • 972.12K
  • John Doyle
  • Chief Financial Officer and Principal Accounting Officer
  • 737.26K
  • Jack A. Khattar
  • Chairman of the Board
  • 145.11K
  • Dr. Aaron G.L. Fletcher, PhD
  • Independent Director
  • 74.61K
  • Ellen B. Richstone
  • Independent Director
  • 83.61K
  • Dr. Brett P. Monia, PhD
  • Independent Director
  • 79.61K
  • Peggy Wallace
  • Independent Director
  • 76.11K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data